Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib

Lung carcinoma is the leading cause of death by cancer in the world. Nowadays, most patients will experience disease progression during or after first-line chemotherapy demonstrating the need for new, effective second-line treatments. The only approved second-line therapies for patients without targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrales, Luis, Nogueira, Amanda, Passiglia, Francesco, Listi, Angela, Caglevic, Christian, Giallombardo, Marco, Raez, Luis, Santos, Edgardo, Rolfo, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329017/
https://www.ncbi.nlm.nih.gov/pubmed/28293555
http://dx.doi.org/10.3389/fmed.2017.00013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5329017/
https://www.ncbi.nlm.nih.gov/pubmed/28293555
http://dx.doi.org/10.3389/fmed.2017.00013

Ejemplares similares